Literature DB >> 1925980

Involvement of the intestinal microflora in nitrazepam-induced teratogenicity in rats and its relationship to nitroreduction.

S Takeno1, T Sakai.   

Abstract

A study was undertaken to investigate the relationship between nitroreduction of nitrazepam and its teratogenic effects and the involvement of the intestinal microflora in Sprague-Dawley rats. Incubation of bacterial suspensions from rat cecal contents with nitrazepam resulted in extensive reduction to 7-aminonitrazepam. Rat liver homogenates also reduced nitrazepam but only under anaerobic conditions. Following oral administration of 300 mg/kg nitrazepam to pregnant rats, total excretion of reduced metabolites (7-aminonitrazepam and 7-acetylaminonitrazepam) in urine and feces accounted for approximately 30% of the administered dose. When antibiotics were administered to dams to deplete their intestinal microflora prior to administration to nitrazepam, the total excretion of the reduced metabolites in the urine and feces decreased to 2% of the dose. Nitroreductase activity of cecal contents was almost completely suppressed by antibiotic pretreatment, but the activity of liver homogenates was not significantly altered by the same treatment. The incidence of nitrazepam-induced malformations was markedly decreased by antibiotic pretreatment. These results suggest that the intestinal microflora plays an important role in the reductive metabolism of nitrazepam and that the teratogenicity of nitrazepam may be related to its nitroreduction by the microflora.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925980     DOI: 10.1002/tera.1420440209

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  18 in total

1.  Manganese-induced sex-specific gut microbiome perturbations in C57BL/6 mice.

Authors:  Liang Chi; Bei Gao; Xiaoming Bian; Pengcheng Tu; Hongyu Ru; Kun Lu
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-10       Impact factor: 4.219

Review 2.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

Review 3.  Individual susceptibility to arsenic-induced diseases: the role of host genetics, nutritional status, and the gut microbiome.

Authors:  Liang Chi; Bei Gao; Pengcheng Tu; Chih-Wei Liu; Jingchuan Xue; Yunjia Lai; Hongyu Ru; Kun Lu
Journal:  Mamm Genome       Date:  2018-02-10       Impact factor: 2.957

4.  Separating host and microbiome contributions to drug pharmacokinetics and toxicity.

Authors:  Michael Zimmermann; Maria Zimmermann-Kogadeeva; Rebekka Wegmann; Andrew L Goodman
Journal:  Science       Date:  2019-02-07       Impact factor: 47.728

Review 5.  Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

Authors:  Ian D Wilson; Jeremy K Nicholson
Journal:  Transl Res       Date:  2016-08-13       Impact factor: 7.012

Review 6.  Bioavailability Based on the Gut Microbiota: a New Perspective.

Authors:  Feng Zhang; Fang He; Li Li; Lichun Guo; Bin Zhang; Shuhuai Yu; Wei Zhao
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-29       Impact factor: 11.056

7.  Effects of bacterial and presystemic nitroreductase metabolism of 2-chloro-5-nitro-N-phenylbenzamide on its mutagenicity and bioavailability.

Authors:  Izet M Kapetanovic; Alexander V Lyubimov; Elena V Kabirova; Kasim K Kabirov; Laura Rasay; Robert Swezey; Carol Green; Levy Kopelovich
Journal:  Chem Biol Interact       Date:  2012-03-19       Impact factor: 5.192

Review 8.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

Review 9.  Review: Mechanisms of How the Intestinal Microbiota Alters the Effects of Drugs and Bile Acids.

Authors:  Curtis D Klaassen; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2015-08-10       Impact factor: 3.922

Review 10.  The influence of gut microbiota on drug metabolism and toxicity.

Authors:  Houkai Li; Jiaojiao He; Wei Jia
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-10       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.